Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
0.1% RGN-259 (Thymosin 4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
Dose escalation is guided by your provider based on your response and tolerability
Subcutaneous Injections After diluting the peptide with water, it is ready for use
Current evidence suggests that CoQ10 supplementation is generally safe for the kidneys and may offer potential protective effects, though more robust clinical trials are needed to establish definitive therapeutic benefits
If the results are as strong as TRIUMPH-4 suggests, Lilly could potentially seek priority review, which would shorten the timeline by several months
much of the nutrient is excreted
